Form 4 for MRNA Moderna
Accepted 2025-03-03 00:00:00 ET · period of report 2025-02-28 · accession 0001127602-25-007545 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| DM | 2025-03-03 | 2025-02-28 | MRNA | Hoge Stephen | Pres | F - Tax | $31.09 | -612 | 1.45M | -0.0% | -$19.0K |
| DM | 2025-03-03 | 2025-02-28 | MRNA | Hoge Stephen | Pres | M - OptEx | — | +1,263 | 1.45M | +0.1% | — |
| DM | 2025-03-03 | 2025-02-28 | MRNA | Hoge Stephen | Pres | M - OptEx | $0.00 | -1,263 | 4,884 | -21% | $0 |
| DM | 2025-03-03 | 2025-03-01 | MRNA | Hoge Stephen | Pres | A - Grant | $0.00 | +386.6K | 148.5K | New | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2025-02-28 | F | D | 296 | $31.09 | 1,450,727 | D | — | — | |
| 2 | Common | Common Stock | 2025-02-28 | M | A | 611 | — | 1,451,023 | D | — | — | (F1) Restricted stock units convert into common stock on a one-for-one basis. |
| 3 | Common | Common Stock | 2025-02-28 | F | D | 316 | $31.09 | 1,450,412 | D | — | — | |
| 4 | Common | Common Stock | 2025-02-28 | M | A | 652 | — | 1,450,728 | D | — | — | (F1) Restricted stock units convert into common stock on a one-for-one basis. |
| 5 | Derivative | Restricted Stock Units | 2025-02-28 | M | D | 652 | $0.00 | 2,607 | D | — · — to — | 652 Common Stock | (F1) Restricted stock units convert into common stock on a one-for-one basis. (F4) 25% of the shares subject to this restricted stock unit award vested on March 1, 2023 with the remainder vesting in twelve (12) equal quarterly installments thereafter. |
| 6 | Derivative | Restricted Stock Units | 2025-02-28 | M | D | 611 | $0.00 | 4,884 | D | — · — to — | 611 Common Stock | (F1) Restricted stock units convert into common stock on a one-for-one basis. (F5) 25% of the shares subject to this restricted stock unit award vested on February 28, 2024 with the remainder vesting in twelve (12) equal quarterly installments thereafter. |
| 7 | Derivative | Stock Option (Right to Buy) | 2025-03-01 | A | A | 238,043 | $0.00 | 238,043 | D | $30.96 · 2026-03-01 to 2035-03-01 | 238,043 Common Stock | (F6) 25% of this option will vest and become exercisable on March 1, 2026 with the remainder vesting in twelve (12) equal quarterly installments thereafter. |
| 8 | Derivative | Restricted Stock Units | 2025-03-01 | A | A | 148,524 | $0.00 | 148,524 | D | — · — to — | 148,524 Common Stock | (F1) Restricted stock units convert into common stock on a one-for-one basis. (F7) 25% of the shares subject to this restricted stock unit award will vest on March 1, 2026 with the remainder vesting in twelve (12) equal quarterly installments thereafter. |